October 21, 2016 7:15 PM ET


Company Overview of Cytovax Biotechnologies Inc.

Company Overview

As of December 3, 2004, Cytovax Biotechnologies Inc. was acquired by Millenium Biologix Corp. in a reverse merger transaction. Cytovax Biotechnologies, Inc. engages in the research, development, and commercialization of peptide vaccines and monoclonal antibody (MAb) therapeutics for the prevention and treatment of infectious diseases, including those caused by antibiotic resistant bacteria. The company has developed Anti-Adhesin Technology and Coiled-Coil Technology that can be used to develop vaccines and therapeutic Mabs. The company’s lead product, Cytovaxine, a peptide conjugate vaccine for the prevention of infections caused by Pseudomonas aeruginosa, completed a Phase I clinical trial....

8223 Roper Road

Edmonton, AB T6E 6S4


Founded in 1998



Key Executives for Cytovax Biotechnologies Inc.

Cytovax Biotechnologies Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cytovax Biotechnologies Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.